Conference icon

Conference

A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (PTS) with metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH PTS

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, Clinical Lab Sciences, Biomedical Research Centre
Role:
Author
Expand authors...
Volume:
17
Pages:
122-122
Publication date:
2006-01-01
ISSN:
0923-7534
URN:
uuid:57dfb72e-7fe9-49a2-87ff-040cd16b386e
Source identifiers:
346464
Local pid:
pubs:346464

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP